Pt(IV) Prodrugs Bearing Sunitinib-Derived Ligands Display Exceptional Anticancer Activity against Renal Cell Carcinoma When Compared to Conventional Platinum Chemotherapy
1. 系统已在2025-11-22 15:05:02对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1021/acs.jmedchem.5c02196
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c02196
其他信息:
出版社: American Chemical Society (ACS)
作者: Darren F. Beirne; Jemma Arakelyan; Matteo Forner; Ho-Jung Choe; Kirill Kriukov; Eithne Dempsey; Valentina Gandin; Trinidad Velasco-Torrijos; Maria V. Babak; Diego Montagner
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c02196

